Jan Trøst Jørgensen
Jan Trøst Jørgensen publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, on topics such as HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research and Cancer Genomics and Diagnostics.
- World rank
- #1,635,913 of 7,710,434 ranked researchers
- Rank in Denmark
- #12,402 of 43,819
- Works
- 111
- Citations
- 2.3k
- Citations per work
- 20.5
What does Jan Trøst Jørgensen research?
Jan Trøst Jørgensen's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5448.7%
- Medicine5448.7%
- Everything else3934.9%
- Life Sciences1816.4%
- 1Oncology26% of their works
- 2Radiology, Nuclear Medicine and Imaging12% of their works
- 3Pulmonary and Respiratory Medicine10% of their works
- 4Cancer Research8% of their works
- 5Molecular Biology5% of their works
- 6Genetics4% of their works
Research topics
Which keywords describe Jan Trøst Jørgensen's research?
The keywords of their largest research topics: Chemotherapy, Targeted Therapy, Breast Cancer, HER2, Monoclonal Antibodies, Fc Receptors, Therapeutic Antibodies and Cancer Genomics.
- Molecular Docking
- Biosimilars
- Immune Checkpoint Blockade
- Cetuximab
- ALK Inhibitors
- Cancer Genomics
- Fc Receptors
- HER2
- Targeted Therapy
- Chemotherapy
- Breast Cancer
- Monoclonal Antibodies
- Therapeutic Antibodies
- Mutational Signatures
- EGFR Mutations
- KRAS Mutations
- PD-1 and PD-L1
- Immunogenicity
- Virtual Screening
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Chemotherapy512 topics
- Targeted Therapy392 topics
- Breast Cancer381 topic
- HER2381 topic
- Monoclonal Antibodies352 topics
- Fc Receptors271 topic
- Therapeutic Antibodies271 topic
- Cancer Genomics201 topic
- Mutational Signatures201 topic
- ALK Inhibitors191 topic
- EGFR Mutations191 topic
- Cetuximab131 topic
- KRAS Mutations131 topic
- Immune Checkpoint Blockade91 topic
- PD-1 and PD-L191 topic
- Biosimilars81 topic
- Immunogenicity81 topic
- Molecular Docking81 topic
- Virtual Screening81 topic
Where does Jan Trøst Jørgensen work?
Jan Trøst Jørgensen's main affiliation in the publication record is Agilent Technologies (Denmark), Denmark.
How many publications and citations does Jan Trøst Jørgensen have?
OpenAlex counts 111 works and 2,274 citations for Jan Trøst Jørgensen, an h-index of 25, ranking #1,635,913 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jan Trøst Jørgensen. Posts are plain text and can be reported.